RICH1 inhibits breast cancer stem cell traits through activating kinases cascade of Hippo signaling by competing with Merlin for binding to Amot-p80

YAP and β-catenin cooperate to drive oncogenesis in basal breast cancer

(2021) Hazel M. Quinn et al.   CANCER RESEARCH

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Critical roles of phosphoinositides and NF2 in Hippo pathway regulation

(2020) Audrey W. Hong et al.   GENES & DEVELOPMENT

SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation

(2020) Peiyuan Zhang et al.   Nature Communications

NEDD 4L‐mediated Merlin ubiquitination facilitates Hippo pathway activation

(2020) Yiju Wei et al.   EMBO REPORTS

High-Molecular-Weight Hyaluronan Is a Hippo Pathway Ligand Directing Cell Density-Dependent Growth Inhibition via PAR1b

(2019) Takuya Ooki et al.   DEVELOPMENTAL CELL

TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling

(2019) Rongxuan Zhu et al.   Nature Communications

STRIPAK integrates upstream signals to initiate the Hippo kinase cascade

(2019) Rui Chen et al.   NATURE CELL BIOLOGY

TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription

(2019) Jin-mei Yu et al.   Nature Communications

Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network

(2018) Marina Kiso et al.   INTERNATIONAL JOURNAL OF CANCER

STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling

(2018) Lufeng Zheng et al.   Journal of Hematology & Oncology

Epithelial-Mesenchymal Transition Directs Stem Cell Polarity via Regulation of Mitofusin

(2018) Meng-Ju Wu et al.   Cell Metabolism

Loss of Par3 promotes prostatic tumorigenesis by enhancing cell growth and changing cell division modes

(2018) Pei-Jie Zhou et al.   ONCOGENE

β1 integrin–dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin

(2017) Hiba Sabra et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Regulation of localization and function of the transcriptional co-activator YAP by angiomotin

(2017) Susana Moleirinho et al.   eLife

Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer

(2015) Michael D. Brooks et al.   Cell Stem Cell

Nadrin GAP activity is isoform- and target-specific regulated by tyrosine phosphorylation

(2014) S. Beck et al.   CELLULAR SIGNALLING

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells

(2014) M Bartucci et al.   ONCOGENE

The role of NADRIN, a Rho GTPase-activating protein, in the morphological differentiation of astrocytes

(2013) Y. Kobayashi et al.   JOURNAL OF BIOCHEMISTRY

Isoform-specific roles of the GTPase activating protein Nadrin in cytoskeletal reorganization of platelets

(2012) S. Beck et al.   CELLULAR SIGNALLING

A Tight Junction-Associated Merlin-Angiomotin Complex Mediates Merlin's Regulation of Mitogenic Signaling and Tumor Suppressive Functions

(2011) Chunling Yi et al.   CANCER CELL

The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells

(2011) Michelangelo Cordenonsi et al.   CELL

Epithelial cell polarity: a major gatekeeper against cancer?

(2011) C Royer et al.   CELL DEATH AND DIFFERENTIATION

Role of YAP/TAZ in mechanotransduction

(2011) Sirio Dupont et al.   NATURE

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

(2009) C. J. Creighton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA